By Akash Sriram, Abhirup Roy, Juby Babu (Reuters) -Electric vehicle makers Rivian and Lucid warned of higher costs from U.S. tariffs on imported vehicles and auto parts, even as automakers scramble to rework sourcing of critical supplies and minimize disruption. The specter of tariffs comes amid already slowing EV sales as economic uncertainty sours sentiment …
EV makers Rivian, Lucid flag increasing costs as tariffs bite Read More »
By Tom Polansek CHICAGO (Reuters) – U.S. Senator Josh Hawley said on Tuesday he launched an investigation into Tyson Foods after a former employee of the meat company alleged that children worked at one of its processing plants. The meat industry has come under increased pressure from federal regulators and activists to adopt safer labor …
US senator investigates claims of child labor at Tyson Foods plant Read More »
By David Shepardson (Reuters) -The U.S. Transportation Department is working with airlines to cut flights at New Jersey’s Newark Liberty International Airport and boost air traffic staffing after hundreds of flights have been disrupted since April 28, Secretary Sean Duffy said on Tuesday. Duffy told CNN the department is in the process of bringing together …
US wants airlines to cut flights at Newark to reduce ongoing woes Read More »
(Reuters) -Activist investor Glenview Capital said on Tuesday it had reduced its holdings in CVS Health following the insurer’s “healthy” first-quarter results. CVS shares have generated a total return of 25% since it took a position last year, suggesting progress in the company’s turnaround plan, the hedge fund said. Glenview previously owned nearly 12 million …
Activist Glenview cuts stake in CVS after strong first-quarter earnings Read More »
By Dan Levine and Julie Steenhuysen (Reuters) -The U.S. Food and Drug Administration has named Vinay Prasad, an oncologist who has previously criticized FDA leadership and COVID-19 mandates, as the director of its Center for Biologics Evaluation and Research, the agency said on Tuesday. In that role, Prasad, a frequent critic of the pharmaceutical industry, …
US FDA names agency critic Vinay Prasad as top vaccine official Read More »
By Michael Erman NEW YORK (Reuters) -Pharmaceutical imports to the U.S. surged in March as drugmakers stocked up ahead of potential U.S. tariffs on their products, which have historically been exempt from such fees. Total imports of pharmaceutical products exceeded $50 billion in the month – the equivalent of 20% of all pharmaceutical imports in …
Pharma imports to US surged in March as drugmakers look to avoid tariffs Read More »
By Raphael Satter WASHINGTON (Reuters) -Israel’s NSO Group was handed a $168 million penalty by a federal jury in California on Tuesday for hijacking the servers of WhatsApp in order to hack users of the Meta-owned chat platform on behalf of foreign spy agencies. The case caps a six-year battle between the American social media …
Meta suit against Israel’s NSO offered rare insight into world of cyberespionage Read More »
By Zaheer Kachwala (Reuters) -Electronic Arts forecast fiscal 2026 bookings above Wall Street expectations on Tuesday, as the videogame publisher bets on the strong performance of its sports titles and the launch of a new “Battlefield” game. EA’s shares surged more than 6% in extended trading as the launch of “Battlefield” this fiscal fills the …
EA forecasts annual bookings above estimates with new ‘Battlefield’ game Read More »
(Reuters) -CoverGirl-parent Coty cut fiscal 2025 profit forecast on Tuesday and postponed its investor day by at least a few months due to macroeconomic and tariff uncertainty, sending its shares down about 3% in extended trading. U.S. President Donald Trump’s erratic trade policies have fueled fears of an imminent recession, prompting customers — who are …
Coty cuts forecast, delays investor day as economic uncertainty hits US market Read More »
(Reuters) -Wynn Resorts posted first-quarter results that missed Wall Street estimates on Tuesday, owing to sluggish business across its luxury resorts. The company reported a revenue fall of 8.7% at its Macau-based Wynn Palace and a 19.9% fall in revenue at Wynn Macau. Shares of Wynn were down 2.4% in after-market trading. They have fallen …
Wynn Resorts posts downbeat quarterly results due to slowdown across its properties Read More »
